Prompted by the global challenges brought on by the COVID-19 pandemic, the World Health Organization (WHO) is recommending that all pharmaceutical control labs – whether private or national – should ...

The Development: China's State Council issued new Anti-Monopoly Guidelines for the Pharmaceutical Sector (the "Guidelines") effective January 24, 2025. The Guidelines provide a comprehensive framework ...

Earlier this year, Argentine intellectual property law firm Berken IP reported that Argentina had signed a Reciprocal Trade and Investment Agreement with the United States that included several ...

Pharmaceutical companies and EU industry groups pushed back against the expectation for sponsors to justify their choice to use adaptive clinical trial designs in the International Council on ...

Drugs for serious or life-threatening diseases can receive expedited U.S. Food and Drug Administration (FDA) review, allowing patients to receive faster access to promising new treatments. Under the ...

CDSCO has tightened drug quality reporting rules amid rising NSQ cases. New digital reporting standards aim to improve ...

Research has documented numerous conflicts of interest (COI) in which pharmaceutical industry money is paid to researchers, APA board members, New studies reveal that conflicted FDA speakers are up to ...

Objective: To determine whether an intervention focusing clinicianattention on drug choice for hypertension treatment improvesconcordance between drug regimens and guidelines. Study Design: ...

Following established guidelines about prescription drugs would seem to be an obvious course of action, especially for the professionals that do the prescribing. Yet doctors and their family members ...

The revised framework directs drug inspectors to prepare monthly and annual sampling plans covering the entire jurisdiction.